Serotonergic input to cholinergic neurons in the substantia innominata and nucleus basalis magnocellularis in the rat

Neuroscience

Volumn 91, Issue 3, 1999, Pages 1129-1142

  Gasbarri, A ^a   Sulli, A ^a   Pacitti, C ^a   McGaugh, J L ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acetylcholine; Dorsal raphe nucleus; Double immunohistochemistry; Nucleus basalis magnocellularis; Serotonin; Substantia innominata

Indexed keywords

CHOLINE ACETYLTRANSFERASE; FLUOROGOLD; LEUKOAGGLUTININ; TRYPTOPHAN HYDROXYLASE;

ANIMAL TISSUE; ARTICLE; CELL CONTACT; CHOLINERGIC NERVE CELL; DORSAL RAPHE NUCLEUS; IMMUNOHISTOCHEMISTRY; MALE; MEDIAN RAPHE NUCLEUS; NEUROANATOMY; NONHUMAN; OLIVARY NUCLEUS; PEDUNCULAR ANSA; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; VENTRAL TEGMENTUM;

ANIMALS; CHOLINE O-ACETYLTRANSFERASE; FLUORESCENT DYES; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; PHYTOHEMAGGLUTININS; RATS; RATS, WISTAR; SEROTONIN; STILBAMIDINES; SUBSTANTIA INNOMINATA; TRYPTOPHAN HYDROXYLASE;

EID: 0032908302     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00672-1     Document Type: Article

References (68)

1. Alheid G.F, Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience. 27:1988;1-39.
2. Arai H., Kosaka K., Iizuka R. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia. J. Neurochem. 43:1984;388-393.
3. Arendt T., Bigl V., Arendt A., Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease. Ann. Neurol. 10:1983;499-505.
4. Bigl V., Arendt T. and Biesolf D. (1990) The nucleus basalis of Meynert during ageing and in dementing neuropsychiatric disorders. In Brain Cholinergic Systems (eds Steriade M. and Biesold D.), pp. 364-386. Oxford University Press, New York.
5. Bigl V., Woolf N.J, Butcher L.L Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis. Brain Res. Bull. 8:1982;727-749.
6. Bolam J.P, Ingham C.A, Izzo P.N, Rye D.B, Smith A.D, Wainer B.H Substance P-containing terminals in synaptic contact with cholinergic neurons in the neostriatum and basal forebrain: a double immunocytochemical study in the rat. Brain Res. 397:1986;279-289.
7. Bondareff W., Mountjoy C.Q, Roth M. Loss of neurons or origin of the adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Neurology. 32:1982;164-169.
8. Cross A.J, Crow T.J, Ferrier I.N, Johnson J.A The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia. Neurobiol. Aging. 7:1986;3-7.
9. Curcio C.A, Kemper T. Nucleus raphe dorsalis in dementia of the Alzheimer-type: neurofibrillary changes and neuronal packing density. J. Neuropath. exp. Neurol. 43:1984;359-368.
10. Dahlström A., Fuxe K. Evidence for the existence of monoamine containing neurons in the central nervous system. I. Demonstration of monoamines in cell bodies of brainstem neurons. Acta physiol. scand., Suppl. 62:1964;1-55.
11. Decker M.W, McGaugh J.L The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse. 7:1991;151-168.
12. Fibiger H.C The organization and some projections of cholinergic neurons of the mammalian forebrain. Brain Res. Rev. 4:1982;327-388.
13. Frazer A. and Hensler J. G. (1994) Serotonin. In Basic Neurochemistry (eds Siegel G. J., Agranoff B. W., Albers R. W. and Molinoff P. B.), pp. 283-308. Raven, New York.
14. Gasbarri A., Packard M.G, Sulli A., Pacitti C., Innocenzi R., Perciavalle V. The projections of the retro rubral field (A8) to the hippocampal formation in the rat. Expl Brain Res. 112:1996;244-252.
15. Gasbarri A., Verney C., Innocenzi R., Campana E., Pacitti C. Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study. Brain Res. 668:1994;71-79.
16. Gasbarri A., Verney C., Innocenzi R., Sulli A. Combination of retrograde fluoro gold tracing and tyrosine hydroxylase immunohistochemistry. Neurosci. Prot. 7:1996;1-9.
17. German D.G, White C.L, Sparkmann D.R Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex. Neuroscience. 21:1987;305-312.
18. Gottfries C.G Transmitter deficit in Alzheimer's disease. Neurochem. Int. 7:1985;565-566.
19. Gritti I., Mainville L., Jones B.E Codistribution of GABA with acetylcholine-synthesizing neurons in the basal forebrain of the rat. J. comp. Neurol. 329:1993;438-457.
20. Gritti I., Mainville L., Mancia M., Jones B.E GABAergic and other noncholinergic basal forebrain neurons, together with cholinergic neurons, project to the mesocortex and isocortex in the rat. J. comp. Neurol. 383:1997;163-177.
21. Hardy J., Adolfsson R., Alafuzoff I., Bucht G., Marcusson J., Nyberg P., Perdahl E., Wester P., Winblad B. Transmitter deficits in Alzheimer's disease. Neurochem. Int. 7:1985;545-563.
22. Heimer L., Harlan R.E, Alheid G.F, Garcia M.M, De Olmos J. Substantia innominata: a notion which impedes clinical-anatomical correlations in neuropsychiatric disorders. Neuroscience. 76:1997;957-1006.
23. Heimer L., Kalil R. Rapid transneuronal degeneration and death of cortical neurons following removal of the olfactory bulb in adult rat. J. comp. Neurol. 178:1978;559-609.
24. Ichimiya Y., Arai H., Kosaka K., Iizuka R. Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia. Acta neuropath. 70:1987;112-116.
25. Ingham C.A, Bolam J.P, Wainer B.H, Smith A.D A correlated light and electron microscopic study of identified cholinergic basal forebrain neurons that project to the cortex in the rat. J. comp. Neurol. 239:1985;176-192.
26. Jacobs R. W. and Butcher L. L. (1986) Pathology of the basal forebrain in Alzheimer's disease and other dementias. In The Biological Substrates of Alzheimer's Disease (eds Scheibel A. B. and Wechsler A. F.), pp. 87-100. Academic, New York.
27. Jennes L., Stumpf W.E, Kalivas P.W Neurotensin: topographical distribution in the rat brain by immunohistochemistry. J. comp. Neurol. 210:1982;211-224.
28. Jones B.E, Cuello A.C Afferents to the basal forebrain cholinergic cell area from pontomesencephalic-catecholamine, serotonin, and acetylcholine neurons. Neuroscience. 31:1989;37-61.
29. Khachaturian H., Lewis M.E, Watson S.J Enkephalin systems in diencephalon and brainstem of the rat. J. comp. Neurol. 220:1983;310-320.
30. Köhler C., Chan-Palay V., Wu J.Y Septal neurons containing glutamic acid decarboxylase immunoreactivity project to the hippocampal region in the rat brain. Anat. Embryol. 169:1984;41-44.
31. Lehmann J., Nagy J., Atmadja S., Fibiger H.C The nucleus basalis magnocellularis: the origin of a cholinergic projection to the neocortex of the rat. Neuroscience. 5:1980;1161-1174.
32. Ljungdahl Å. T., Hökfelt T., Nilsson G. Distribution of substance P-like immunoreactivity in the central nervous system of the rat - I. Cell bodies and terminals. Neuroscience. 3:1978;861-943.
33. Luiten P.G.M., Gaykema R.P.A., Traber J., Spencer D.G Jr. Cortical projection pattern of magnocellular basal nucleus subdivisions as revealed by anterogradely transported Phaseolus vulgaris leucoagglutinin. Brain Res. 413:1987;229-250.
34. Markowska A.L, Wenk G.L Serotonin influences the behavioral recovery of rats following nucleus basalis lesions. Pharmac. Biochem. Behav. 38:1991;731-737.
35. Mesulam M.-M. (1988) Central cholinergic pathways: neuroanatomy and some behavioral implications. In Neurotransmitters and Cortical Function (eds Avoli M., Reader T. A., Dykes R. W. and Gloor P.), pp. 237-260. Plenum, New York.
36. Mesulam M.-M., Mufson E.J, Wainer B.H, Levey A.I Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience. 10:1983;1185-1201.
37. Mesulam M.-M., Mufson E.J, Levey A.I, Wainer B.H Cholinergic innervation of the cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata) and hypothalamus in the rhesus monkey. J. comp. Neurol. 214:1983;170-197.
38. Moss M.S, Glazer E.J, Basbaum A.I Enkephalin-immunoreactive perikarya in the cat raphe dorsalis. Neurosci. Lett. 21:1981;33-37.
39. Nilsson O.G, Strecker R.E, Daszuta A., Björklund A. Combined cholinergic and serotonergic denervation of the forebrain produces severe deficits in a spatial learning task in the rat. Brain Res. 453:1988;235-246.
40. Normile H.J, Jenden J.J, Kuhn D.M, Wolf W.A, Altman H.J Effects of combined serotonin depletion and lesions of the nucleus basalis magnocellularis on acquisition of a complex spatial discrimination task in the rat. Brain Res. 536:1990;245-250.
41. Palkovits M. Distribution of neuropeptides in the central nervous system: a review of biochemical mapping studies. Prog. Neurobiol. 23:1984;151-189.
42. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
43. Perry E. K. (1987) Cortical neurotransmitter chemistry in Alzheimer's disease. In Psychopharmachology: The Third Generation of Progress (ed. Meltzer H. Y.), pp. 887-895. Raven, New York.
44. Richter-Levin G., Segal M. Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission. Brain Res. 477:1989;404-407.
45. Riekkinen M. Jr., Sirviö J., Riekkinen P. Jr. Pharmacological consequences of nicotinergic plus serotonergic manipulations. Brain Res. 662:1993;139-146.
46. Riekkinen P. Jr., Sirviö J., Aaltonen M., Riekkinen P. Effects of concurrent manipulation of nicotinic and muscarinic receptors on spatial learning. Pharmac. Biochem. Behav. 37:1990;405-410.
47. Riekkinen P. Jr., Sirviö J., Riekkinen P. Interaction between raphe dorsalis and nucleus basalis magnocellularis in spatial learning. Brain Res. 527:1990;342-345.
48. Riekkinen P. Jr., Jäkälä P., Sirviö J., Riekkinen P. The effects of increased serotonergic and decreased cholinergic activities on spatial navigation performance in rats. Pharmac. Biochem. Behav. 39:1991;25-29.
49. Riekkinen P. Jr., Sirviö J., Valjakka A., Miettinen R., Riekkinen P. Pharmacological consequences of cholinergic plus serotonergic manipulations. Brain Res. 552:1991;23-26.
50. Rye D.B, Wainer B.H, Mesulam M.-M., Mufson E.J, Saper C.B Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase. Neuroscience. 13:1984;627-643.
51. Saper C.B Organization of cerebral cortical afferent systems in the rat. II. Magnocellular basal nucleus. J. comp. Neurol. 222:1984;313-342.
52. Satoh K., Armstrong D.M, Fibiger H.C A comparison of the distribution of central cholinergic neurons as demonstrated by acetylcholinesterase pharmacohistochemistry. Brain Res. Bull. 11:1983;693-720.
53. Schwaber J.S, Rogers W.T, Satoh K., Fibiger H.C Distribution and organization of cholinergic neurons in the rat forebrain demonstrated by computer-aided data acquisition and three-dimensional reconstruction. J. comp. Neurol. 263:1987;309-325.
54. Semba K., Reiner F.B, McGeer E.G, Fibiger H.C Brainstem afferents to the magnocellular basal forebrain studied by axonal transport, immunohistochemistry, and electrophysiology in the rat. J. comp. Neurol. 267:1988;433-453.
55. Steinbusch H.W.M. Distribution of serotonin-immunoreactivity in the central nervous system of the rat - cell bodies and terminals. Neuroscience. 6:1981;557-618.
56. Steinbusch H. W. M. and Nieuwenhuys R. (1983) The raphe nuclei of the rat brainstem: a cytoarchitectonic and immunohistochemical study. In Chemical Neuroanatomy (ed. Emson P. C.), pp. 131-207. Raven, New York.
57. Steward O., Rubel E.W Afferent influences on brain stem auditory nuclei of the chicken: cessation of amino acid incorporation as antecedent to age-dependent transneuronal degeneration. J. comp. Neurol. 231:1985;385-395.
58. Uhl G.R, Kuhar M.J, Snyder S.H Neurotensin: immunohistochemical localization in rat nervous system. Proc. natn. Acad. Sci. U.S.A. 74:1977;4059-4063.
59. Vanderwolf C.H Near-total loss of "learning" and "memory" as a result of combined cholinergic and serotonergic blockade in the rat. Behav. Brain Res. 23:1987;43-57.
60. Whitehouse P. J. (1985) In Neuronal Loss and Transmitter Receptor Alterations in Alzheimer's and Parkinson's Disease (eds Fisher A., Hanin I. and Lachman C.), pp. 85-94. Plenum, New York.
61. Whitehouse P.J, Price D.L, Clark A.W, Coyle J.T, De Long M.R Alzheimer's disease. Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10:1981;122-126.
62. Whitford G.M Alzheimer's disease and serotonin: a review. Neuropsychobiology. 15:1986;133-142.
63. Wilcock G.K, Esiri M.M, Bowen D.M, Smith C.C.T. Alzheimer's disease: correlation of cortical choline acetyltransferase activity with severity of dementia and histological abnormalities. J. neurol. Sci. 57:1982;407-417.
64. Woolf N.J Cholinergic systems in mammalian brain and spinal cord. Prog. Neurobiol. 37:1991;475-524.
65. Woolf N.J, Eckenstein F., Butcher L.L Cholinergic systems in rat brain: I. Projections to the limbic telencephalon. Brain Res. Bull. 13:1984;751-784.
66. Yamamoto T., Hirano A. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Ann. Neurol. 17:1985;573-577.
67. Yates C.M, Simpson J., Gordon A. Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease. Neurosci. Lett. 65:1986;189-192.
68. Záborszky L., Heimer L., Eckenstein F., Leranth C. GABAergic input to cholinergic forebrain neurons: an ultrastructural study using retrograde tracing of HRP and double immunolabeling. J. comp. Neurol. 250:1986;282-295.